$13.75 is a reasonable 12-month price target, particularly given that the company will IMO need to downgrade again before the end of the FY. Has anyone on here figured out how the company will actually achieve the forecast $1b+ in revenue for 2HY? That's well in excess of what the company achieved in the pcp when there was mass stockpiling that inflated the pcp figure. So the company is saying it's going to blow that figure out of the water. How? Because the company said it's going to? It also said in late August that it expected strong revenue growth only for that to be throw out barely a month later. So what the company says should be taken with a grain of salt at this juncture, IMO.
- Forums
- ASX - By Stock
- A2M
- Bell Potter = Sell $13.75
Bell Potter = Sell $13.75, page-41
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.78 |
Change
-0.040(0.83%) |
Mkt cap ! $3.460B |
Open | High | Low | Value | Volume |
$4.80 | $4.87 | $4.73 | $16.45M | 3.420M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $4.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.78 | 4935 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 4.750 |
2 | 15277 | 4.740 |
3 | 15200 | 4.730 |
4 | 59491 | 4.720 |
3 | 18485 | 4.710 |
Price($) | Vol. | No. |
---|---|---|
4.780 | 4935 | 1 |
4.790 | 43483 | 2 |
4.800 | 32053 | 2 |
4.830 | 3500 | 1 |
4.850 | 28421 | 3 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online